Literature DB >> 25369593

Correction of knee flexion contracture at the time of surgical fixation of a femoral supracondylar fracture in a haemophiliac with inhibitors.

Laura Candiotto1, Franco W Fullone2, Alberto Ricciardi2, Paolo Radossi1, Giuseppe Tagariello1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25369593      PMCID： PMC4385087          DOI： 10.2450/2014.0149-14

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  8 in total

1.  Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion.

Authors:  G Tagariello; R Bisson; P Radossi; U Petris; G Zanardo; E De Biasi; R Risato; F Polese; P G Davoli
Journal:  Haemophilia       Date:  2003-11       Impact factor: 4.287

2.  The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients.

Authors:  V Crooks; S Waller; T Smith; T J Hahn
Journal:  J Gerontol       Date:  1991-07

Review 3.  Orthopedic surgery is possible in hemophilic patients with inhibitors.

Authors:  E Carlos Rodríguez-Merchán
Journal:  Am J Orthop (Belle Mead NJ)       Date:  2012-12

4.  Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.

Authors:  U Hedner; S Glazer; K Pingel; K A Alberts; M Blombäck; S Schulman; H Johnsson
Journal:  Lancet       Date:  1988-11-19       Impact factor: 79.321

5.  Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.

Authors:  G Tagariello; E De Biasi; G B Gajo; R Risato; P Radossi; P G Davoli; A Traldi
Journal:  Haemophilia       Date:  2000-09       Impact factor: 4.287

6.  Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.

Authors:  Peter W Collins; Elizabeth Chalmers; Daniel P Hart; Ri Liesner; Savita Rangarajan; Kate Talks; Mike Williams; Charles R Hay
Journal:  Br J Haematol       Date:  2012-11-15       Impact factor: 6.998

7.  Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV.

Authors:  Sarah C Darby; Sau Wan Kan; Rosemary J Spooner; Paul L F Giangrande; Frank G H Hill; Charles R M Hay; Christine A Lee; Christopher A Ludlam; Michael Williams
Journal:  Blood       Date:  2007-04-19       Impact factor: 22.113

Review 8.  Consensus recommendations for the use of FEIBA(®) in haemophilia A patients with inhibitors undergoing elective orthopaedic and non-orthopaedic surgery.

Authors:  S Rangarajan; S Austin; N J Goddard; C Négrier; E C Rodriguez-Merchan; D Stephensen; T T Yee
Journal:  Haemophilia       Date:  2012-09-19       Impact factor: 4.287
  8 in total
  1 in total

Review 1.  Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.

Authors:  Madhvi Rajpurkar; David L Cooper
Journal:  J Blood Med       Date:  2018-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.